Investing in health tech to tackle Indonesia’s greatest challenges
The COVID-19 pandemic has exposed critical gaps in Indonesia’s healthcare infrastructure, revealing structural and systemic shortcomings requiring scalable solutions. Change doesn’t happen overnight, particularly for the healthcare sector, which consists of multiple intertwined industries with strict regulatory oversight. But because the industry is highly regulated, regulations play a huge role in shaping trends.
Buoyant life sciences sector emerges stronger
As we bid farewell to another eventful year in the world of life sciences, it's time to look back at the whirlwind of advancements and changes that have shaped the industry in 2023. Back in January this year, we interacted with leaders from various market segments who shared their insights into what the year held for their particular spheres. Let's recap the 2023 predictions and find out if they panned out as predicted.
Moosa Genetics, an animal genomics and biotechnology startup, announced a new funding led by East Ventures
Moosa Genetics, an animal genomics and biotechnology startup based in Indonesia, announced that the company raised funding led by East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia, with the participation from angel investors. This funding will be allocated to build laboratory, team, marketing, and wagyu partnership to fulfill the demand for its customers.
Genetic testing: Leading the way in preventive care for Southeast Asia
In a region plagued by diseases such as heart disease, stroke, cancer, diabetes and neonatal deaths, NalaGenetics is taking a stand. As a prominent provider of genetic testing solutions, this pioneering company is on a mission to combat these ailments and improve patient outcomes in Southeast Asia.
AMILI, a precision gut microbiome firm, raises new funding led by East Ventures
AMILI, Southeast Asia’s first and only precision gut microbiome company, today announced that it has secured new funding from East Ventures, a pioneering sector-agnostic venture capital firm that has supported over 300 tech companies across Southeast Asia. This fund strengthens AMILI’s balance sheet, following the company’s series A funding in June 2022.
How private and public sectors can collaborate to advance the Indonesian healthcare system
East Ventures has recently launched the White paper: “Genomics: Leapfrogging into the Indonesian healthcare future”, a collaborative report with Indonesia’s Health Ministry and a global consulting company, Redseer, on 16 February 2022, in Jakarta, Indonesia.
East Ventures launched a white paper on genomics in collaboration with the Ministry of Health of the Republic of Indonesia
East Ventures today launched a white paper “Genomics: Leapfrogging into the Indonesian healthcare future” in collaboration with the Ministry of Health of the Republic of Indonesia and Redseer Strategy Consultants, to provide a comprehensive understanding of how genomics can improve the healthcare system in Indonesia. This white paper serves as a guide for stakeholders in taking the necessary steps to improve our healthcare system and infrastructure for the future.
Why Indonesia should embrace genomics now
Two of the most critical pain points of Indonesia's healthcare system is the high mortality rates for non-communicable diseases, and high cost of treatment. The solution to this is developing genomics. Genomics technology will allow for early detection and targeted treatment, paving the way ahead to transform our healthcare system.